Ketogenic Diet Biochemistry
On this page
Direct answer
Ninety per cent of calories from fat, classically a 4:1 ratio of fat to protein-plus-carbohydrate by weight: the ketogenic diet restricts carbohydrate until hepatic mitochondrial HMG-CoA synthase diverts acetyl-CoA into acetoacetate and beta-hydroxybutyrate, and blood ketones rise into the millimolar range. The brain, denied fatty-acid entry, adapts over days — monocarboxylate transporters carry ketones across the blood-brain barrier, and after full adaptation they supply a majority of cerebral energy while glucose needs and proteolysis fall. The standing indication is drug-resistant childhood epilepsy, and two disorders where the diet is first-line rather than last resort: glucose transporter 1 deficiency and pyruvate dehydrogenase deficiency, each treated by supplying the missing or bypassed fuel.
What you must remember
- Composition numbers: classical diet 4:1 (or 3:1) fat to protein-plus-carbohydrate by weight, near 90 per cent of energy from fat; the modified Atkins diet relaxes the ratio for tolerability; medium-chain triglyceride diets generate more ketones per calorie, allowing more carbohydrate and protein.
- The three ketone bodies: acetoacetate, beta-hydroxybutyrate (the abundant one, a reduced storage form) and acetone (volatile, the breath odour); beta-hydroxybutyrate to acetoacetate in blood is roughly 4:1 in sustained ketosis.
- Urine-strip trap: nitroprusside strips detect acetoacetate (and acetone weakly), not beta-hydroxybutyrate — so a recovering patient deepening in beta-hydroxybutyrate may show a lighter urine test; blood beta-hydroxybutyrate meters are the reliable monitor.
- Antiepileptic mechanisms, list them: ATP-sensitive potassium channel opening from raised ATP-to-ADP ratios, increased GABA synthesis (glutamate decarboxylation favoured), reduced aspartate release, adenosine A1 signalling, mitochondrial biogenesis, and beta-hydroxybutyrate's histone deacetylase inhibition.
- First-line indications: GLUT1 deficiency (cerebral hypoglycorrhachia — low CSF glucose with normal plasma) and pyruvate dehydrogenase deficiency (ketones bypass the blocked enzyme).
- Contraindications: fatty-acid beta-oxidation defects (MCAD, LCHAD, carnitine transporter problems), primary carnitine deficiency, pyruvate carboxylase deficiency — each worsened by demanding fat oxidation or gluconeogenesis; porphyria is also commonly listed.
- Side effects to recite: growth slowing in children, constipation, nephrolithiasis (classically around 5-6 per cent), dyslipidaemia, acidosis, hypoglycaemia at initiation, and micronutrient gaps (selenium, vitamin D, folate, B vitamins) requiring supplementation.
- Physiological ketosis versus ketoacidosis: diet maintains insulin sufficient to restrain lipolysis, with beta-hydroxybutyrate in low millimoles and buffered acids; diabetic ketoacidosis exceeds 20 mmol/L with overwhelming acidosis — categorically different states.
GLUT1 deficiency, the diet as fuel replacement
A two-year-old develops seizures, then developmental slowing and an abnormal gait; a lumbar puncture shows CSF glucose about a third of plasma (normally around two-thirds) with normal lactate — the signature of glucose transporter 1 deficiency, where mutated GLUT1 starves the brain at the blood-brain barrier. Anticonvulsants underperform because the problem is fuel delivery, not excitability. The ketogenic diet answers the biochemistry directly: ketones cross the barrier on monocarboxylate transporters, a separate gate that does not need GLUT1, and become the brain's substrate; seizures often improve within weeks and the diet remains therapy for years. Pyruvate dehydrogenase deficiency is the mirror case — the defect sits inside mitochondria, converting pyruvate to acetyl-CoA — and exogenous ketones deliver acetyl-CoA-derived acetoacetate past the blocked step, also reducing the lactic acidosis. Both disorders make the teaching point examiners reward: in selected inborn errors, a diet is not adjunctive therapy but metabolic substitution.
Where students slip
Three slips recur. First, "ketones are toxic" — written without distinguishing physiological ketosis (buffered, low-millimolar, insulin-guarded) from ketoacidosis; the correcting sentence should name insulin as the variable that keeps lipolysis bounded. Second, the urine-strip paradox: monitoring recovery with nitroprusside strips is misleading precisely when beta-hydroxybutyrate predominates, a favourite MCQ built on a real clinical error. Third, mechanism lists reduce to "ketones feed the brain", losing the marks carried by KATP channels, GABA and HDAC inhibition. The Indian angle is practical: a vegetarian ketogenic diet is genuinely feasible — coconut oil and medium-chain triglyceride preparations, ghee, paneer, cream and nuts supply the fat — but requires a trained dietitian, and families attempting unsupervised "keto" for weight loss in children deserve a caution about growth and micronutrients. In epilepsy clinics the diet is a prescribed therapy, not a food trend.
Frequently asked questions
What is the composition of the classical ketogenic diet?
A 4:1 ratio of fat to protein-plus-carbohydrate by weight, roughly 90 per cent of energy from fat, initiated gradually under supervision with micronutrient supplementation.
How does the brain meet its energy needs during ketosis?
Ketones cross the blood-brain barrier on monocarboxylate transporters and, after adaptation, supply a majority of cerebral energy, reducing obligatory glucose and sparing muscle protein.
Why do urine ketone strips fail to track beta-hydroxybutyrate?
Nitroprusside strips react with acetoacetate only, so a rising beta-hydroxybutyrate fraction — the dominant ketone in sustained ketosis — can register weakly; blood meters measure it directly.
Which disorders make the ketogenic diet first-line therapy?
Glucose transporter 1 deficiency and pyruvate dehydrogenase deficiency, where ketones substitute for the missing fuel or bypass the blocked enzyme.
Why is the diet contraindicated in fatty-acid oxidation defects?
The diet demands massive hepatic fat oxidation; in MCAD or carnitine-cycle defects that capacity is absent, risking hypoketotic hypoglycaemia, rhabdomyolysis and cardiac dysfunction.